Clinton Wright
Overview
Explore the profile of Clinton Wright including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sheikh M, Moon Y, Wright C, Gutierrez J, Rundek T, Cheung K, et al.
Neurology
. 2025 Feb;
102(7_supplement_1):6876.
PMID: 39977946
Objective: To determine whether a panel of immune markers adds significant information to known correlates of risk of dementia and cognitive impairment. Background: The impact of immune mechanisms on dementia...
2.
Melgarejo J, Gurel K, Compton C, Liu M, Guzman V, Assuras S, et al.
Alzheimers Dement
. 2024 Feb;
20(4):2497-2507.
PMID: 38332543
Introduction: We tested the association of brain artery diameters with dementia and stroke risk in three distinct population-based studies using conventional T2-weighted brain magnetic resonance imaging (MRI) images. Methods: We...
3.
Beaman C, Kozii K, Hilal S, Liu M, Spagnolo-Allende A, Polanco-Serra G, et al.
Neurology
. 2022 Mar;
98(16):e1605-e1616.
PMID: 35228332
Background And Objectives: Age-related cognitive impairment is driven by the complex interplay of neurovascular and neurodegenerative disease. There is a strong relationship between cerebral microbleeds (CMBs), cerebral amyloid angiopathy (CAA),...
4.
Brown J, Wakim P, Faraco C, Saugar-Lanchas C, Lungu C, Mendoza-Puccini C, et al.
Ann Neurol
. 2021 Oct;
90(6):861-864.
PMID: 34713927
No abstract available.
5.
Katan M, Moon Y, von Eckardstein A, Spanaus K, DeRosa J, Gutierrez J, et al.
Stroke
. 2017 Jan;
48(3):604-610.
PMID: 28123058
Background And Purpose: Chronic infections and cardiac dysfunction are risk factors for stroke. We hypothesized that blood biomarkers of infection (procalcitonin) and cardiac dysfunction (midregional proatrial natriuretic peptide [MR-proANP]), previously...
6.
Loewenstein D, Curiel R, Wright C, Sun X, Alperin N, Crocco E, et al.
J Alzheimers Dis
. 2017 Jan;
56(3):1119-1126.
PMID: 28106554
Background: There is growing evidence that proactive semantic interference (PSI) and failure to recover from PSI may represent early features of Alzheimer's disease (AD). Objective: This study investigated the association...
7.
Gonzalez H, Tarraf W, Gouskova N, Rodriguez C, Rundek T, Grober E, et al.
J Alzheimers Dis
. 2016 Jun;
53(3):955-65.
PMID: 27340845
Background: Hispanics/Latinos are purportedly at increased risk for neurocognitive decline and dementias. Without dementia cures, low-cost, well-tolerated public health means for mitigating neurocognitive decline are needed. Objective: We examined associations...
8.
Gupta A, Giambrone A, Gialdini G, Finn C, Delgado D, Gutierrez J, et al.
Stroke
. 2016 Feb;
47(3):719-25.
PMID: 26888534
Background And Purpose: Silent brain infarction (SBI) on magnetic resonance imaging has been proposed as a subclinical risk marker for future symptomatic stroke. We performed a systematic review and meta-analysis...
9.
Barone F, Gustafson D, Crystal H, Moreno H, Adamski M, Arai K, et al.
J Transl Med
. 2016 Feb;
14:50.
PMID: 26873444
As the human population continues to age, an increasing number of people will exhibit significant deficits in cognitive function and dementia. It is now recognized that cerebrovascular, metabolic and neurodegenerative...
10.
Del Brutto O, Wright C
Geriatr Gerontol Int
. 2015 Jan;
15(1):126-7.
PMID: 25583395
No abstract available.